B
Bull
Bull · 25%CCM
$5.00
Scenario price
$4.760
-0.136 (-2.86%)At close
Loading chart…
- High
- 4.950
- Open
- 4.950
- VWAP
- 4.76
- Vol
- 37.23K
- Mkt Cap
- 35.82M
- Low
- 4.570
- Amount
- 177.20K
- EV/EBITDA, TTM
- 0.00
Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market.
AI analysis of Concord Medical Services Holdings Ltd (CCM)
holdConcord Medical Services Holdings Ltd is not a strong buy right now due to its current price of 4.76, which is down 10.02% over the last five days. The RSI is at 41.963, indicating it is nearing oversold territory but not quite there yet. The forward P/E ratio of 11.2994 suggests potential value, but the negative price-to-book ratio of -0.010116 raises concerns about the company's asset valuation. The main risk is the recent performance, with a 1-year change of -9.07%, indicating a lack of upward momentum.
Analyst Ratings (1)
Sell
0 Buy
0 Hold
1 Sell
Current: 4.76
Low
—
Average
—
High
—
Valuation Metrics
The current forward P/E ratio for Concord Medical Services Holdings Ltd (CCM) is 11.30, compared to its 5-year average forward P/E of -32.75.
Alphio AI Price Scenarios for CCM
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
4.506-24Yahoo FinanceAsian Equities Rise as ADRs Track Higher in the US
9.504-29PRnewswireConcord Medical Files Annual Report for 2025
9.504-29NewsfilterConcord Medical Files Annual Report for 2025
9.512-05BenzingaUlta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading
- 1.012-02PRnewswire
Concord Medical to Hold 2025 Annual Shareholders Meeting on December 29
CCM FAQ — answered by Alphio AI
Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector (OFFICES AND CLINICS OF DOCTORS OF MEDICINE industry).
Concord Medical Services Holdings Ltd is not a strong buy right now due to its current price of 4.76, which is down 10.02% over the last five days. The RSI is at 41.963, indicating it is nearing oversold territory but not quite there yet. The forward P/E ratio of 11.2994 suggests potential value, but the negative price-to-book ratio of -0.010116 raises concerns about the company's asset valuation. The main risk is the recent performance, with a 1-year change of -9.07%, indicating a lack of upward momentum.
1 analysts cover CCM: 0 rate it Buy, 0 Hold and 1 Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.